Bernstein, Jonathan A. http://orcid.org/0000-0002-3476-1196
Llanos, Jean-Pierre http://orcid.org/0000-0002-7785-6881
Hunter, Gillian
Martin, Neil
Ambrose, Christopher S. http://orcid.org/0000-0003-4175-7336
Funding for this research was provided by:
AstraZeneca
Amgen
Article History
Received: 14 July 2023
Accepted: 14 August 2023
First Online: 12 September 2023
Declarations
:
: Jonathan A. Bernstein has served as a consultant for Amgen, AstraZeneca, Genentech, Merck, Novartis and Sanofi Regeneron; has participated in research with Amgen, AstraZeneca, Genentech, Merck, Novartis and Sanofi Regeneron; and has received speaker fees from AstraZeneca, Genentech, GSK, Novartis, Optinose and Sanofi Regeneron. Jean-Pierre Llanos is an employee of Amgen and owns stock in Amgen. Gillian Hunter, Neil Martin and Christopher S. Ambrose are employees of AstraZeneca and may own stock or stock options in AstraZeneca.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.